Paper

Journal of Commercial Biotechnology (2006) 12, 192–199; doi:10.1057/palgrave.jcb.3040166

Commercial biotechnology in Latin America: Current opportunities and challenges

Fernando Quezada

Biotechnology Center of Excellence Corporation, 371 Moody Street, Suite 109, Waltham, MA, 02453, USA, Tel: +1 (781) 894 7457, Fax: +1 (781) 894 7459, Email: bcec@mindspring.com

Received 11 October 2005.

Top

Abstract

The unparalleled growth of commercial biotechnology in the USA and Europe during the past two decades has also been marked by its steady development in Latin America. Brazil, Cuba, Argentina, Chile, Mexico and others have made significant strides in building their research and production capacity in modern biotechnology. As these countries have pioneered new biotechnology applications in agriculture, mining, biofuels, human and animal healthcare a number have also launched national biotechnology plans with long-term investment commitments. Newly formed biotechnology trade associations in the region are expanding their membership and rapidly gaining international visibility. Along with the growth of commercial biotechnology in Latin America comes the need to address a series of issues associated with public perception, regulatory framework and intellectual property protection, financing mechanisms, workforce development and more. Government agencies and related public institutions are challenged to adjust their policies and operations to address these changing needs. The private sector and the international community at large will continue to play critical roles in the region through knowledge networks, technology exchanges and joint business investments.

Keywords:

Latin America, biotechnology, Mexico, Chile, Brazil, pharmaceuticals, economic development

Extra navigation

.
ADVERTISEMENT